CCME Global approves ₹180 crore preferential issue and 1:10 stock split

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Approved preferential allotment of equity shares aggregating up to ₹180 crore
  • Sanctioned sub-division of equity shares in a 1:10 ratio to enhance liquidity
  • Authorized shift of registered office from Andhra Pradesh to Mumbai
  • Appointed M/s Desai Saksena & Associates as statutory auditors for five years
powered bylight_fuzz_icon
52248048

*this image is generated using AI for illustrative purposes only.

CCME Global Limited shareholders approved a preferential allotment of equity shares aggregating up to ₹180 crore during the 34th Annual General Meeting held on September 29, 2026. The resolutions also authorized a sub-division of shares and the acquisition of stakes in two UAE-based entities.

The meeting, conducted via video conferencing, ratified the appointment of M/s Desai Saksena & Associates as statutory auditors for five years. Members also approved the regularization of Ms. Ami Oza as an Independent Non-Executive Director.

Capital Structure Changes

The board proposed increasing the authorized share capital from ₹60 crore to ₹200 crore. This increase is intended to accommodate the proposed further issue and allotment of equity shares.

Particulars Existing Proposed
Authorized Share Capital ₹60 crore ₹200 crore
Number of Equity Shares 6,00,00,000 20,00,00,000
Face Value ₹10 ₹10

Additionally, members approved a sub-division of equity shares in a 1:10 ratio. Each existing equity share with a face value of ₹10 will be split into ten fully paid-up equity shares with a face value of ₹1 each. The management expects to complete this activity in FY27.

Preferential Allotment Details

The company plans to issue equity shares through three distinct preferential allotments:

  1. For Cash: Up to 1,80,00,000 equity shares at ₹10 per share, aggregating up to ₹18 crore. Investors include Mr. Muhammed Noor Habibullah, Mr. Suresh Kumar Ramani, and Mr. Vidhu Mohan Pillai.
  2. For Acquisition of CCME UAE: Up to 11,25,00,000 equity shares at ₹10 per share, aggregating to ₹112.50 crore, for acquiring 45% of Cash & Carry Middle East FZCO. Promoters Mr. Padmanabhan Krishnamoorthy and Ms. V. Varalakshmi are the allottees.
  3. For Acquisition of Interlink: Up to 2,03,42,244 equity shares at ₹10 per share, aggregating to ₹20.34 crore, for acquiring 52% of Interlink Distribution LLC. Mr. Mostafa Ahmed Kabir is the sole non-promoter allottee.

Governance and Operational Shifts

The AGM approved shifting the registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra. The rationale cited was the relocation of the corporate office, operations, and accounts teams to Mumbai following a change in management.

Ms. Ami Oza was regularized as an Independent Non-Executive Director for a term of five years. She holds an LL.M. in Business Laws and has over 10 years of experience in corporate and regulatory laws.

What the Numbers Show

The total value of the proposed preferential issues aggregates to approximately ₹150.84 crore (₹18 crore cash + ₹112.50 crore swap + ₹20.34 crore swap). Notably, the acquisition of CCME UAE constitutes 74.5% of the total value of these new issuances, indicating a significant strategic pivot toward consolidating promoter-held assets into the listed entity. The post-allotment paid-up capital is projected to rise to ₹196.09 crore from the current structure, assuming full subscription of all proposed shares.

Historical Stock Returns for CCME Global

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%+20.15%+15.67%0.0%0.0%0.0%

How will the consolidation of promoter-held UAE assets into the listed entity impact CCME Global's minority shareholder dilution and future governance standards?

What specific revenue synergies or cost efficiencies does management project from acquiring 45% of Cash & Carry Middle East FZCO and 52% of Interlink Distribution LLC?

How might the shift of the registered office to Mumbai and the regularization of new independent directors influence CCME Global's credibility with institutional investors?

CCME Global closes trading window from Oct 1 for Q2FY27 results

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Restriction applies to designated persons and relatives
  • Window reopens 48 hours after Q2FY27 results declaration
powered bylight_fuzz_icon
52135105

*this image is generated using AI for illustrative purposes only.

CCME Global Limited has closed its trading window for all designated persons effective October 1, 2026. The closure remains in force until 48 hours after the company declares its unaudited standalone financial results for the second quarter and half year of FY27.

This action complies with the company's Code of Conduct and the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The restriction applies to directors, key managerial personnel, employees, and auditors, prohibiting them from dealing in the company's equity shares during this period.

Scope of restrictions

The trading window closure covers all designated persons and their immediate relatives. The company has formally intimated these individuals to refrain from trading in equity shares until the specified release time.

The board meeting date for considering the unaudited financial results for Q2FY27 and H1FY27, ending September 30, 2026, will be announced in due course.

Historical Stock Returns for CCME Global

1 Day5 Days1 Month6 Months1 Year5 Years
-4.98%+20.15%+15.67%0.0%0.0%0.0%

How might the upcoming Q2FY27 financial results impact CCME Global's stock volatility once the trading window reopens?

What are the current analyst consensus estimates for CCME Global's revenue and profit margins for the first half of FY27?

Are there any pending regulatory investigations or compliance issues that could influence the timing of the board meeting announcement?

More News on CCME Global

1 Year Returns:0.00%